NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $51,000 | -81.8% | 108,541 | -52.7% | 0.00% | – |
| Q4 2021 | $280,000 | -46.6% | 229,400 | +62.9% | 0.00% | – |
| Q3 2021 | $524,000 | +6.5% | 140,800 | -4.6% | 0.00% | – |
| Q2 2021 | $492,000 | -36.3% | 147,562 | -15.9% | 0.00% | – |
| Q1 2021 | $772,000 | – | 175,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $214,000 | 0.02% |
| UBS Group AG | 1,037 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 371 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 323 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 24,642 | $92,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 728 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 60,792 | $226,000 | 0.00% |
| STATE STREET CORP | 15,878 | $59,000 | 0.00% |
| MORGAN STANLEY | 141 | $0 | 0.00% |